Litcius/Paper detail

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

Patrick Cheung, Samir Patel, Scott North, Arjun Sahgal, William Chu, Hany Soliman, Belal Ahmad, Eric Winquist, Tamim Niazi, François Patenaude, Gerald Lim, Daniel Yick Chin Heng, Arbind Dubey, Piotr Czaykowski, Rebecca Wong, Anand Swaminath, Scott C. Morgan, Rupi Mangat, Sareh Keshavarzi, Georg A. Bjarnason

2021European Urology125 citationsDOI

Topics & Concepts

MedicineInternal medicineRenal cell carcinomaCumulative incidenceOncologyProspective cohort studyTyrosine-kinase inhibitorRadiation therapyIncidence (geometry)Confidence intervalSystemic therapyCancerSurgeryCohortPhysicsOpticsBreast cancerRenal cell carcinoma treatmentBrain Metastases and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study | Litcius